共 133 条
[1]
Postmus PE(2017)Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol. 28 1-21
[2]
Kerr KM(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30
[3]
Oudkerk M(2017)Management of stage III non-small cell lung cancer Semin Oncol 44 163-177
[4]
Senan S(2006)Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients Ann Oncol 17 473-483
[5]
Waller DA(2010)Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2181-2190
[6]
Vansteenkiste J(2011)Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410 J Natl Cancer Inst 103 1452-1460
[7]
Siegel RL(1999)Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 2692-2699
[8]
Miller KD(2017)Comparison of concurrent use of thoracic radiation with either carboplatin-paclitaxel or cisplatin-etoposide for patients with stage III non-small-cell lung cancer: a systematic review JAMA Oncol 3 1120-1129
[9]
Jemal A(2004)Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study Lung Cancer (Amsterdam, Netherlands) 46 87-98
[10]
Tabchi S(2010)Concurrent chemoradiotherapy in non-small cell lung cancer Cochrane Database Syst Rev 6 140-135